Related Experiment Video
Updated: Jun 26, 2026
08:04
Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
Published on: December 20, 2017
7.0K
A candidate multi-epitope vaccine against Lumpy skin disease
Md Bashir Uddin1,2, Fatema Yeasmin Tanni1, Syeda Farjana Hoque3
1Department of Medicine, Sylhet Agricultural University, Sylhet, Bangladesh.
Transboundary and Emerging Diseases
|October 2, 2022
Summary
A novel multi-epitope vaccine for lumpy skin disease (LSD) was designed using in silico methods. This computational approach identified stable vaccine candidates, like construct V2, predicted to induce robust immune responses in cattle.
Area of Science:
- Veterinary immunology
- Bioinformatics
- Vaccine development
Background:
- Lumpy skin disease (LSD) is a significant cattle infection causing global economic losses.
- Current control strategies for LSD are limited, necessitating novel vaccine approaches.
Purpose of the Study:
- To design and computationally validate a multi-epitope subunit vaccine against lumpy skin disease (LSD).
- To utilize reverse vaccinology and bioinformatics for identifying optimal vaccine candidates.
Main Methods:
- In silico reverse vaccinology approach applied to identify T-cell and B-cell epitopes from key LSD viral proteins.
- Bioinformatic analyses including antigenicity, allergenicity, conservancy, and toxicity assessments.
- Development of three subunit vaccine constructs (V1, V2, V3) and selection of the most promising candidate (V2) based on structural and immunological simulations.
Main Results:
- Identification of potent epitopes and development of three multi-epitope subunit vaccine constructs.
- Construct V2 was selected as the lead candidate due to favorable antigenicity, solubility, and structural validation.
- Molecular dynamics and immunological simulations indicated construct V2's stability and potential to elicit humoral and cellular immunity.
Conclusions:
- The in silico designed multi-epitope subunit vaccine (construct V2) shows promise as a stable and immunogenic candidate against lumpy skin disease.
- Further in vitro and in vivo studies are warranted to validate the efficacy of this novel vaccine approach.
Related Concept Videos
00:42Cross-reactivity
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...